This switch in response to TGF-β by tumor cells is accompanied by epithelial-to-mesenchymal transition (EMT), as well as the enhancement of a number of cancer cell hallmarks, including angiogenesis, invasion and metastasis [8,21]. This evidence concerns the gene TGFB1 and neoplasm.